ERBB2 and breast carcinoma: Our data showed that the expression of CILK1 in four major breast cancer subtypes including Luminal A, Luminal B, HER2+ and Triple-negative, was significantly higher than that of adjacent normal breast tissues (Fig. 1B, S1A).